It is used to control, prevent and normalize the symptoms associated with Alzheimer's disease, attention disorder, bipolar disorder, Parkinson's disease among others
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
The RTP manufacturing facility will support the company's clinical studies and early commercial launch in North America and Europe
Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company
The transaction generates upfront cash proceeds of $442 million for Syncona's holding in Gyroscope
The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.
Funding to grow the insurance and digital therapeutics vertical in India
The entire integration and transition of the brands is expected to be completed by March 2022
It will open new frontier for south-to-south collaboration and innovation transfer
AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia
Subscribe To Our Newsletter & Stay Updated
